Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats

Podocalyxin (PCX) is a signature molecule of the glomerular podocyte and of maintaining integrity of filtration function of glomerulus. The aim of this study was to observe the effect of different doses of metformin on renal tissue PCX expression in type 2 diabetic rats and clarify its protection on...

Full description

Saved in:
Bibliographic Details
Main Authors: Limin Zhai, Junfei Gu, Di Yang, Wei Wang, Shandong Ye
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2015/231825
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567698134925312
author Limin Zhai
Junfei Gu
Di Yang
Wei Wang
Shandong Ye
author_facet Limin Zhai
Junfei Gu
Di Yang
Wei Wang
Shandong Ye
author_sort Limin Zhai
collection DOAJ
description Podocalyxin (PCX) is a signature molecule of the glomerular podocyte and of maintaining integrity of filtration function of glomerulus. The aim of this study was to observe the effect of different doses of metformin on renal tissue PCX expression in type 2 diabetic rats and clarify its protection on glomerular podocytes. Type 2 diabetic Sprague-Dawley (SD) rats in which diabetes was induced by high-fat diet/streptozotocin (HFD-STZ) were treated with different doses of metformin (150, 300, and 500 mg/kg per day, resp.) for 8 weeks. Various biochemical parameters, kidney histopathology, and renal tissue PCX expression levels were examined. In type 2 diabetic rats, severe hyperglycemia and hyperlipidemia were developed. Urinary albumin and PCX were markedly increased. Diabetes induced significant alterations in renal glomerular structure. In addition, protein and mRNA expression of renal tissue PCX were highly decreased. However, treatment of rats with different doses of metformin restored all these changes to a varying degree. These results suggested that metformin can ameliorate glomerular podocyte damage in type 2 diabetic rats, which may be partly associated with its role in restoring PCX expression and inhibiting urinary excretion of PCX with dose dependence.
format Article
id doaj-art-fc4cde9a8e49434bb039d809f2c5b408
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-fc4cde9a8e49434bb039d809f2c5b4082025-02-03T01:00:54ZengWileyJournal of Diabetes Research2314-67452314-67532015-01-01201510.1155/2015/231825231825Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic RatsLimin Zhai0Junfei Gu1Di Yang2Wei Wang3Shandong Ye4Department of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaDepartment of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaDepartment of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaDepartment of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaDepartment of Endocrinology, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei 230001, ChinaPodocalyxin (PCX) is a signature molecule of the glomerular podocyte and of maintaining integrity of filtration function of glomerulus. The aim of this study was to observe the effect of different doses of metformin on renal tissue PCX expression in type 2 diabetic rats and clarify its protection on glomerular podocytes. Type 2 diabetic Sprague-Dawley (SD) rats in which diabetes was induced by high-fat diet/streptozotocin (HFD-STZ) were treated with different doses of metformin (150, 300, and 500 mg/kg per day, resp.) for 8 weeks. Various biochemical parameters, kidney histopathology, and renal tissue PCX expression levels were examined. In type 2 diabetic rats, severe hyperglycemia and hyperlipidemia were developed. Urinary albumin and PCX were markedly increased. Diabetes induced significant alterations in renal glomerular structure. In addition, protein and mRNA expression of renal tissue PCX were highly decreased. However, treatment of rats with different doses of metformin restored all these changes to a varying degree. These results suggested that metformin can ameliorate glomerular podocyte damage in type 2 diabetic rats, which may be partly associated with its role in restoring PCX expression and inhibiting urinary excretion of PCX with dose dependence.http://dx.doi.org/10.1155/2015/231825
spellingShingle Limin Zhai
Junfei Gu
Di Yang
Wei Wang
Shandong Ye
Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
Journal of Diabetes Research
title Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
title_full Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
title_fullStr Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
title_full_unstemmed Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
title_short Metformin Ameliorates Podocyte Damage by Restoring Renal Tissue Podocalyxin Expression in Type 2 Diabetic Rats
title_sort metformin ameliorates podocyte damage by restoring renal tissue podocalyxin expression in type 2 diabetic rats
url http://dx.doi.org/10.1155/2015/231825
work_keys_str_mv AT liminzhai metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats
AT junfeigu metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats
AT diyang metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats
AT weiwang metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats
AT shandongye metforminamelioratespodocytedamagebyrestoringrenaltissuepodocalyxinexpressionintype2diabeticrats